GLOBUS MEDICAL INC
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
GMED$76.37+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| (In thousands, except share and per share values) | 2024 | 2023 |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $784,438 | $467,292 |
| Short-term marketable securities | 105,619 | 50,497 |
| Accounts receivable, net of allowances of $15,505 and $8,934, respectively | 557,697 | 503,235 |
| Inventories | 659,233 | 848,135 |
| Prepaid expenses and other current assets | 49,640 | 44,580 |
| Income taxes receivable | 20,633 | 1,635 |
| Total current assets | 2,177,260 | 1,915,374 |
| Property and equipment, net of accumulated depreciation of $545,786 and $425,695, respectively | 561,909 | 586,932 |
| Operating lease right of use assets | 49,647 | 59,931 |
| Long-term marketable securities | 66,134 | 75,428 |
| Intangible assets, net | 795,117 | 924,603 |
| Goodwill | 1,432,387 | 1,434,540 |
| Other assets | 75,096 | 78,590 |
| Deferred income taxes | 94,200 | 10,685 |
| Total assets | $5,251,750 | $5,086,083 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $75,118 | $56,671 |
| Accrued expenses | 260,591 | 240,460 |
| Operating lease liabilities | 10,249 | 11,967 |
| Income taxes payable | 10,725 | 3,845 |
| Senior convertible notes | 443,351 | — |
| Business acquisition liabilities | 33,739 | 61,035 |
| Deferred revenue | 22,140 | 18,369 |
| Total current liabilities | 855,913 | 392,347 |
| Business acquisition liabilities, net of current portion | 89,496 | 78,323 |
| Operating lease liabilities | 83,588 | 91,037 |
| Senior convertible notes | — | 417,400 |
| Deferred income taxes and other tax liabilities | 23,889 | 84,421 |
| Other liabilities | 21,531 | 24,596 |
| Total liabilities | 1,074,417 | 1,088,124 |
| Commitments and contingencies (Note 15) | ||
| Equity: | ||
| Class A common stock; $0.001 par value. Authorized 500,000,000 shares; issued and outstanding 114,990,219 and 113,905,565 shares at December 31, 2024 and December 31, 2023, respectively | 115 | 114 |
| Class B common stock; $0.001 par value. Authorized 275,000,000 shares; issued and outstanding 22,430,097 and 22,430,097 shares at December 31, 2024 and December 31, 2023, respectively | 22 | 22 |
| Additional paid-in capital | 3,031,244 | 2,870,749 |
| Accumulated other comprehensive income/(loss) | (6,861) | (10,192) |
| Retained earnings | 1,152,813 | 1,137,266 |
| Total equity | 4,177,333 | 3,997,959 |
| Total liabilities and equity | $5,251,750 | $5,086,083 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.